Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Within a smoking-cessation program, what impact does genetic information on lung cancer need to have to demonstrate cost-effectiveness?

Gordon LG, Hirst NG, Young RP, Brown PM.

Cost Eff Resour Alloc. 2010 Sep 16;8:18. doi: 10.1186/1478-7547-8-18.

2.

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.

Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. Review.

3.

Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.

Annemans L, Nackaerts K, Bartsch P, Prignot J, Marbaix S.

Clin Drug Investig. 2009;29(10):655-65. doi: 10.2165/11317730-000000000-00000.

PMID:
19715382
4.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
5.

A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.

Xenakis JG, Kinter ET, Ishak KJ, Ward AJ, Marton JP, Willke RJ, Davies S, Caro JJ.

Pharmacoeconomics. 2011 Jun;29(6):497-510. doi: 10.2165/11589230-000000000-00000.

PMID:
21452908
6.

The cost-effectiveness of testing for hepatitis C in former injecting drug users.

Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K.

Health Technol Assess. 2006 Sep;10(32):iii-iv, ix-xii, 1-93.

7.

Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.

Hoogendoorn M, Welsing P, Rutten-van Mölken MP.

Curr Med Res Opin. 2008 Jan;24(1):51-61.

PMID:
18021492
8.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

9.

The cost-effectiveness of the English smoking treatment services: evidence from practice.

Godfrey C, Parrott S, Coleman T, Pound E.

Addiction. 2005 Apr;100 Suppl 2:70-83.

PMID:
15844290
10.

Improving the effectiveness of smoking cessation in primary care: lessons learned.

Richards D, Toop L, Brockway K, Graham S, McSweeney B, MacLean D, Sutherland M, Parsons A.

N Z Med J. 2003 May 2;116(1173):U417.

PMID:
12740611
11.

Cost-effectiveness analysis of the first-line therapies for nicotine dependence.

Cornuz J, Pinget C, Gilbert A, Paccaud F.

Eur J Clin Pharmacol. 2003 Jul;59(3):201-6. Epub 2003 May 21.

PMID:
12759795
12.

[Smoking reduction and temporary abstinence: new approaches for smoking cessation].

Le Houezec J, Säwe U.

J Mal Vasc. 2003 Dec;28(5):293-300. Review. French.

PMID:
14978435
14.

Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment.

Kaper J, Wagena EJ, van Schayck CP, Severens JL.

Pharmacoeconomics. 2006;24(5):453-64.

PMID:
16706571
15.

Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan.

Igarashi A, Takuma H, Fukuda T, Tsutani K.

Pharmacoeconomics. 2009;27(3):247-61. doi: 10.2165/00019053-200927030-00007.

PMID:
19354344
16.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

17.

Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD.

Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mölken MP.

Thorax. 2010 Aug;65(8):711-8. doi: 10.1136/thx.2009.131631. Review.

PMID:
20685746
18.

[Smoking cessation and pregnancy].

Møller AM, Tønnesen H.

Ugeskr Laeger. 1999 Sep 6;161(36):4985-6. Review. Danish.

PMID:
10489788
19.

Cost-effectiveness of treating nicotine dependence: the Mayo Clinic experience.

Croghan IT, Offord KP, Evans RW, Schmidt S, Gomez-Dahl LC, Schroeder DR, Patten CA, Hurt RD.

Mayo Clin Proc. 1997 Oct;72(10):917-24.

PMID:
9379693
20.

Cost-effective primary care-based strategies to improve smoking cessation: more value for money.

Salize HJ, Merkel S, Reinhard I, Twardella D, Mann K, Brenner H.

Arch Intern Med. 2009 Feb 9;169(3):230-5; discussion 235-6. doi: 10.1001/archinternmed.2008.556.

PMID:
19204212
Items per page

Supplemental Content

Write to the Help Desk